Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy

Clinical Medicine Insights: Endocrinology and Diabetes - United Kingdom
doi 10.1177/1179551419883608
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Inter- And Intraspecies Polymorphisms in the Cholecystokinin-B/Gastrin Receptor Alter Drug Efficacy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Cholecystokinin-B/Gastrin Receptors Enhance Wound Healing in the Rat Gastric Mucosa

Journal of Clinical Investigation
Medicine
2000English

New 1,4-Benzodiazepin-2-One Derivatives as Gastrin/Cholecystokinin-B Antagonists.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1995English

Involvement of Central Gastrin and Cholecystokinin in the Regulation of Food Intake in the Neonatal Chick

Journal of Applied Animal Research
Animal ScienceZoologyVeterinary
2000English

Expression of Cholecystokinin-2/Gastrin Receptor in the Murine Pancreas Modulates Cell Adhesion and Cell Differentiation in Vivo

American Journal of Pathology
Forensic MedicinePathology
2004English

Synthesis of Constrained Analogues of Cholecystokinin/Opioid Chimeric Peptides

Tetrahedron Letters
Organic ChemistryBiochemistryDrug Discovery
2006English

Radiolabeled Regulatory Peptides for Imaging and Therapy

Current Opinion in Endocrinology, Diabetes and Obesity
Internal MedicineNutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2010English

Antagonistic Effect of YM022, an Antiulcer Agent in Rats, on Human Cholecystokinin (CCK)B/Gastrin Receptor.

The Japanese Journal of Pharmacology
1996English

Synthesis of Phenoxyacetic Acid Derivatives as Highly Potent Antagonists of Gastrin/Cholecystokinin-B Receptors.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy